Search


 
Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 26 (Search time: 0.001 seconds).
Item hits:
First PublishedTitleAuthor(s)Type
17-Jun-2011A brain-permeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylase.Taylor, DM; Balabadra, U; Xiang, Z; Woodman, B; Meade, S; Amore, A; Maxwell, MM; Reeves, S; Bates, GP; Luthi-Carter, R; Lowden, PA; Kazantsev, AGJournal Article
27-Apr-2010SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis.Luthi-Carter, R; Taylor, DM; Pallos, J; Lambert, E; Amore, A; Parker, A; Moffitt, H; Smith, DL; Runne, H; Gokce, O; Kuhn, A; Xiang, Z; Maxwell, MM; Reeves, SA; Bates, GP; Neri, C; Thompson, LM; Marsh, JL; Kazantsev, AGJournal Article
Oct-2009Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons.Rudinskiy, N; Kaneko, YA; Beesen, AA; Gokce, O; Régulier, E; Déglon, N; Luthi-Carter, RJournal Article
Aug-2010Developmental expression of Synaptotagmin isoforms in single calyx of Held-generating neurons.Xiao, L; Han, Y; Runne, H; Murray, H; Kochubey, O; Luthi-Carter, R; Schneggenburger, RJournal Article
15-Apr-2010Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis.Becanovic, K; Pouladi, MA; Lim, RS; Kuhn, A; Pavlidis, P; Luthi-Carter, R; Hayden, MR; Leavitt, BRJournal Article
1-Aug-2007Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.Kuhn, A; Goldstein, DR; Hodges, A; Strand, AD; Sengstag, T; Kooperberg, C; Becanovic, K; Pouladi, MA; Sathasivam, K; Cha, JH; Hannan, AJ; Hayden, MR; Leavitt, BR; Dunnett, SB; Ferrante, RJ; Albin, R; Shelbourne, P; Delorenzi, M; Augood, SJ; Faull, RL; Olson, JM; Bates, GP; Jones, L; Luthi-Carter, RJournal Article
15-Jan-2005Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1.Zucker, B; Luthi-Carter, R; Kama, JA; Dunah, AW; Stern, EA; Fox, JH; Standaert, DG; Young, AB; Augood, SJJournal Article
Feb-2006Capucin: a novel striatal marker down-regulated in rodent models of Huntington disease.de Chaldée M; Brochier, C; Van de Vel A; Caudy, N; Luthi-Carter, R; Gaillard, MC; Elalouf, JMJournal Article
15-May-2007Modulation of nucleosome dynamics in Huntington's disease.Stack, EC; Del Signore SJ; Luthi-Carter, R; Soh, BY; Goldstein, DR; Matson, S; Goodrich, S; Markey, AL; Cormier, K; Hagerty, SW; Smith, K; Ryu, H; Ferrante, RJJournal Article
Aug-2010Environmental enrichment reduces neuronal intranuclear inclusion load but has no effect on messenger RNA expression in a mouse model of Huntington disease.Benn, CL; Luthi-Carter, R; Kuhn, A; Sadri-Vakili, G; Blankson, KL; Dalai, SC; Goldstein, DR; Spires, TL; Pritchard, J; Olson, JM; van Dellen A; Hannan, AJ; Cha, JHJournal Article